Agios Pharmaceuticals, Inc. (AGIO) short interest & options flow
NASDAQAgios Pharmaceuticals arrives at the most consequential month of its near-term story with short sellers holding their ground, options traders tilting toward calls, and analysts divided largely by a single question: how much of the sickle cell opportunity is still addressable. The positioning picture is unusually calm for a stock with a binary regulatory date approaching. Short…
- Market cap
- $1.76B
- Next earnings
- 11 Feb 2027
Key data as of 7 Nov 2026

AGIO news and analysis
RSSNo long-form analysis yet for AGIO. Pulse alerts and the live data picture are available on ORTEX.
Open AGIO on ORTEX →Want the live picture for AGIO?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AGIO — free to start on ORTEX.
Sign up for free →Open AGIO on ORTEX